Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kiniksa Pharmaceuticals Ltd.

28.04
-0.4500-1.58%
Post-market: 28.00-0.0400-0.14%17:50 EDT
Volume:8.69M
Turnover:243.78M
Market Cap:2.05B
PE:-118.99
High:28.86
Open:28.50
Low:27.91
Close:28.49
Loading ...

Earnings Flash (KNSA) Kiniksa Pharmaceuticals International Posts Q1 EPS $0.11, vs. FactSet Est of $0.13 per Share

MT Newswires Live
·
29 Apr

Kiniksa Pharmaceuticals Q1 GAAP EPS $0.11 Misses $0.14 Estimate, Sales $137.78M Miss $140.68M Estimate

Benzinga
·
29 Apr

BRIEF-Kiniksa Pharmaceuticals Q1 EPS USD 0.12

Reuters
·
29 Apr

Kiniksa Pharmaceuticals International Plc: Expects 2025 Arcalyst Net Product Revenue of Between $590 Million and $605 Million

THOMSON REUTERS
·
29 Apr

Kiniksa Pharmaceuticals Q1 Pretax Profit USD 15.565 Million

THOMSON REUTERS
·
29 Apr

Kiniksa Pharmaceuticals International Plc: Kpl-387 Phase 2/3 Clinical Trial in Recurrent Pericarditis on Track to Initiate in Mid-2025

THOMSON REUTERS
·
29 Apr

Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution

GlobeNewswire
·
29 Apr

uniQure (QURE) Moves 38.5% Higher: Will This Strength Last?

Zacks
·
21 Apr

Kiniksa Pharmaceuticals Price Target Maintained With a $34.00/Share by Wedbush

Dow Jones
·
16 Apr

Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year?

Zacks
·
08 Apr

Wall Street Analysts Predict a 64.8% Upside in Kiniksa Pharmaceuticals (KNSA): Here's What You Should Know

Zacks
·
04 Apr

How Much Upside is Left in Kiniksa Pharmaceuticals (KNSA)? Wall Street Analysts Think 58.6%

Zacks
·
19 Mar

BUZZ-U.S. STOCKS ON THE MOVE-Metropolitan Bank, Fossil, MeiraGTx

Reuters
·
13 Mar

Kiniksa Pharmaceuticals Initiated at Buy by Citigroup

Dow Jones
·
13 Mar

Citigroup Initiates Coverage on Kiniksa Pharmaceuticals International With Buy Rating, $40 Price Target

MT Newswires Live
·
13 Mar

BUZZ-Citi starts coverage on 'insulated' SMid biotechs amid healthcare policy uncertainty

Reuters
·
13 Mar

Surging Earnings Estimates Signal Upside for Kiniksa Pharmaceuticals (KNSA) Stock

Zacks
·
05 Mar

Kiniksa Pharmaceuticals (KNSA) Soars 5.8%: Is Further Upside Left in the Stock?

Zacks
·
04 Mar

Is Kiniksa Pharmaceuticals International, plc (KNSA) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
03 Mar

US High Growth Tech Stocks With Strong Potential

Simply Wall St.
·
01 Mar